BSE Live
Jan 30, 16:01Prev. Close
4063.00
Open Price
4089.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 30, 15:58Prev. Close
4068.30
Open Price
4065.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
4017.70 (83)
| Cash Flow of Sanofi India (in Rs. Cr.) | Dec 14 | Dec 13 | Dec 12 | Dec 11 | Dec 10 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 306.06 | 363.08 | 261.71 | 283.98 | 234.01 | |
| Net CashFlow From Operating Activities | 264.95 | 272.55 | 286.37 | 205.02 | 130.72 | |
| Net Cash Used In Investing Activities | 61.34 | -335.35 | -3.42 | -478.91 | 104.79 | |
| Net Cash Used From Financing Activities | -121.73 | -104.99 | -88.33 | -147.22 | -55.05 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 204.56 | -167.75 | 194.62 | -421.11 | 180.46 | |
| Cash And Cash Equivalents Begin of Year | 261.10 | 428.85 | 234.23 | 655.34 | 474.95 | |
| Cash And Cash Equivalents End Of Year | 465.66 | 261.10 | 428.85 | 234.23 | 655.41 |
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
01.08.2025
16.07.2025
Emcure Pharma announces deal with Sanofi India to distribute oral anti-diabetic products in India
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
17.03.2025
Sanofi India Consolidated December 2024 Net Sales at Rs 514.90 crore, down 25.8% Y-o-Y
29.07.2024
Sanofi India Consolidated June 2024 Net Sales at Rs 463.50 crore, down 34.36% Y-o-Y